RA patients maintaining DAS@-CRP ( Disease Activity Score of @ joints with C-reactive protein ) scores < @ for @ months with IFX were randomized either to receive addition of bucillamine ( BUC ) to MTX ( BUC + MTX group ; n = @ ) or not ( MTX group ; n = @ ) upon discontinuing IFX .